Chronic liver diseases and erectile dysfunction
Open accessThe DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
Chronic liver diseases (CLDs) are characterized by progressive necrosis of hepatocytes, which leads to liver fibrosis and cirrhosis, and ultimately liver dysfunction. The statistics of 2020 shows that the number of patients with CLDs, including chronic hepatitis, fatty liver, and cirrhosis, may exceed 447 million in China. The liver is a crucial organ for the metabolism of various substances, including sex hormones and lipids. CLDs frequently result in abnormalities in the metabolism of sex hormones, glucose, and lipids, as well as mental and psychological illnesses, all of which are significant risk factors for erectile dysfunction (ED). It has been reported that the prevalence of ED in male patients with CLDs ranges from 24.6 to 85.0%. According to a survey of Caucasians, liver transplantation may improve the erectile function of CLDs patients with ED. This finding supports the link between CLDs and ED. In addition, ED is often a precursor to a variety of chronic diseases. Given this correlation and the significant prevalence of CLDs, it is important to evaluate the epidemiology, risk factors, etiology, and treatment outcomes of ED in male patients with CLDs, expecting to attract widespread attention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“a chronic liver disease is characterized by progressive necrosis of hepatocytes and development of liver dysfunction, which may remarkably affect the metabolism of various substances including proteins, sex hormones and lipids.96”
From The chronic alcohol consumption influences the gonadal axis in men: Results from a meta‐analysis (2024) · cites this paper as [96]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249 · cited 1×
“Currently, it is considered to be the most common CLDs worldwide, especially in the Western, with an incidence of nearly 25% (10).”
BackgroundNitric oxide synthases: regulation and function
Forstermann, U., & Sessa, W. C. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr304 · Cited by 4,409
Burden of liver diseases in the world
Asrani, S. K., Devarbhavi, H., Eaton, J., & Kamath, P. S. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.09.014 · Cited by 3,783 · cited 1×
“69 billion people worldwide were affected by liver disease (5).”
BackgroundFuel selection in human skeletal muscle in insulin resistance: a reexamination.
Kelley, D. E., & Mandarino, L. J. (2000) · Diabetes · doi:10.2337/diabetes.49.5.677 · Cited by 1,017
Paik, J. M., Golabi, P., Younossi, Y., Mishra, A., & Younossi, Z. M. (2020) · Hepatology · doi:10.1002/hep.31173 · Cited by 788
The Hyperdynamic Circulation of Chronic Liver Diseases: From the Patient to the Molecule
Iwakiri, Y., & Groszmann, R. J. (2006) · Hepatology · doi:10.1002/hep.20993 · Cited by 610
Marchesini, G., Bianchi, G., Merli, M., Amodio, P., Panella, C., Loguercio, C., Rossi Fanelli, F., & Abbiati, R. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00323-8 · Cited by 600
Prevalence of Sexual Dysfunction Among Newer Antidepressants
Clayton, A. H., Pradko, J. F., Croft, H. A., Montano, C. B., Leadbetter, R. A., Bolden-Watson, C., Bass, K. I., Donahue, R. M. J., Jamerson, B. D., & Metz, A. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0414 · Cited by 542 · cited 1×
“A multicenter survey conducted by the United States of 1,763 male depressed patients treated with SSRIs found that the incidence of sexual dysfunction ranged from 7 to 30%, with the highest incidence of paroxetine (34%) and the lowest incidence of fluoxetine (7%) (73).”
BackgroundPathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy
Sloan, G., Selvarajah, D., & Tesfaye, S. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00496-z · Cited by 534
Manns, M. P., Buti, M., Gane, E., Pawlotsky, J.-M., Razavi, H., Terrault, N., & Younossi, Z. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.6 · Cited by 506
Erectile Dysfunction in Young Men—A Review of the Prevalence and Risk Factors
Nguyen, H. M. T., Gabrielson, A. T., & Hellstrom, W. J. G. (2017) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2017.05.004 · Cited by 345 · cited 2×
“Additionally, the information currently available points to an increase in the prevalence of ED in men younger than 40 years of age (1).”
BackgroundTestosterone and insulin resistance in the metabolic syndrome and T2DM in men
Rao, P. M., Kelly, D. M., & Jones, T. H. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.122 · Cited by 292 · cited 1×
“In patients with NAFLD, the hypotestosteronemia can be explained by the hypogonadal-obesity-adipocytokine hypothesis (63).”
BackgroundAbramovitch, S., Dahan-Bachar, L., Sharvit, E., Weisman, Y., Tov, A. B., Brazowski, E., & Reif, S. (2011) · Gut · doi:10.1136/gut.2010.234666 · Cited by 286 · cited 2×
“(96, 97) and significantly better than vardenafil, another metaanalysis failed to show this significance (98).”
BackgroundYuan, J., Zhang, R., Yang, Z., Lee, J., Liu, Y., Tian, J., Qin, X., Ren, Z., Ding, H., Chen, Q., et al. (2013) · European Urology · doi:10.1016/j.eururo.2013.01.012 · Cited by 260
Laumann, E. O., Glasser, D. B., Neves, R. C. S., Moreira, E. D., & for the GSSAB Investigators' Group (2009) · International Journal of Impotence Research · doi:10.1038/ijir.2009.7 · Cited by 240
The Relationship Between Type 2 Diabetes, NAFLD, and Cardiovascular Risk
Caussy, C., Aubin, A., & Loomba, R. (2021) · Current Diabetes Reports · doi:10.1007/s11892-021-01383-7 · Cited by 230 · cited 1×
“NAFLD has been regarded as the hepatic manifestation of systemic metabolic syndrome (12, 13).”
BackgroundPDE5 inhibitors as therapeutics for heart disease, diabetes and cancer
Das, A., Durrant, D., Salloum, F. N., Xi, L., & Kukreja, R. C. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.10.003 · Cited by 212 · cited 1×
“PDE5-I can protect the liver from ischemia-reperfusion injury through a variety of signaling pathways, such as increasing intracellular cGMP levels, activating protein kinase C and protein kinase G (93), leading to the activation of cGMP-dependent protein kinase, which in turn induces vasodilation, anti-inflammatory a…”
BackgroundGatselis, N. K. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i1.60 · Cited by 198 · cited 1×
“It may be connected to other autoimmune conditions like diabetes, which can result in hormonal imbalance and disruption of the hypothalamicpituitary-gonad axis, ultimately impairing sexual function (61).”
BackgroundMilić, S., & Štimac, D. (2012) · Digestive Diseases · doi:10.1159/000336669 · Cited by 192
Laurent, M. R., Hammond, G. L., Blokland, M., Jardí, F., Antonio, L., Dubois, V., Khalil, R., Sterk, S. S., Gielen, E., Decallonne, B., et al. (2016) · Scientific Reports · doi:10.1038/srep35539 · Cited by 174 · cited 1×
“That then results in a higher binding between testosterone and sex hormone-binding globulin, further reducing bioactive free testosterone (62, 68).”
BackgroundTestosterone in men with advanced liver disease: Abnormalities and implications
Sinclair, M., Grossmann, M., Gow, P. J., & Angus, P. W. (2015) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12695 · Cited by 161
Effect of Antihypertensive Agents on Quality of Life in the Elderly
Fogari, R., & Zoppi, A. (2004) · Drugs & Aging · doi:10.2165/00002512-200421060-00003 · Cited by 139 · cited 1×
“Non-selective β receptor blockers, such as propranolol and carvedilol, which are widely used to treat portal hypertension, have been shown to have a negative effect on erectile function (72), increasing ED by 2.”
BackgroundAnxiety and erectile dysfunction: a global approach to ED enhances results and quality of life
Hedon, F. (2003) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900994 · Cited by 128
Male Sexual Dysfunction and Chronic Kidney Disease
Edey, M. M. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00032 · Cited by 128 · cited 1×
“Furthermore, anemia reduces the supply of oxygen to tissues, including the corpus cavernosum, potentially impairing erectile function (84).”
BackgroundJaruvongvanich, V., Sanguankeo, A., Riangwiwat, T., & Upala, S. (2017) · Annals of Hepatology · doi:10.5604/01.3001.0009.8593 · Cited by 128
Hypogonadism in Hereditary Hemochromatosis
McDermott, J. H., & Walsh, C. H. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0980 · Cited by 125 · cited 1×
“It can also cause hypothalamic-pituitary-gonadal axis dysfunction, direct testicular damage, diabetes, and other conditions that can lead to sexual dysfunction (59, 60).”
BackgroundNew insights into hypertension-associated erectile dysfunction
Nunes, K. P., Labazi, H., & Webb, R. C. (2012) · Current Opinion in Nephrology and Hypertension · doi:10.1097/mnh.0b013e32835021bd · Cited by 124
Dopamine and Male Sexual Function
Giuliano, F., & Allard, J. (2001) · European Urology · doi:10.1159/000049844 · Cited by 122 · cited 1×
“This adverse side effect could be caused by serotonin, dopamine, acetylcholine, prolactin, NO, or another transmitter (74).”
BackgroundDepression and chronic liver diseases: are there shared underlying mechanisms?
Huang, X., Liu, X., & Yu, Y. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00134 · Cited by 121
Nardelli, S., Pentassuglio, I., Pasquale, C., Ridola, L., Moscucci, F., Merli, M., Mina, C., Marianetti, M., Fratino, M., Izzo, C., et al. (2013) · Metabolic Brain Disease · doi:10.1007/s11011-012-9364-0 · Cited by 114 · cited 1×
“(56) found that the prevalence of ED was significantly higher in patients with abnormal neurocognitive tests than in normal subjects, and that, in the subgroup of patients with Child-Pugh A cirrhosis (n = 25), 100% of patients with minimal hepatic encephalopathy (n = 16) developed ED.”
BackgroundProtein kinase C in enhanced vascular tone in diabetes mellitus
Kizub, I. V., Klymenko, K., & Soloviev, A. I. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.04.117 · Cited by 112 · cited 1×
“First, it can negatively affect endothelial function, resulting in an imbalance between NO and endothelin-1, which causes relaxation disorder of smooth muscle cells (35); second, it can increase the levels of advanced glycosylation end products, which can interfere with the synthesis of protein polymerase chains and m…”
BackgroundDose-Dependent Effects of Recombinant Human Interleukin-6 on the Pituitary-Testicular Axis
Tsigos, C., Papanicolaou, D. A., Kyrou, I., Raptis, S. A., & Chrousos, G. P. (1999) · Journal of Interferon & Cytokine Research · doi:10.1089/107999099312948 · Cited by 111 · cited 1×
“interleukin-1, and interleukin-6, have been shown to inhibit the pituitary axis, which in turn reduces testosterone levels (65).”
Background(2017) · PubMed · doi:10.5604/16652681.1235481 · Cited by 111
Prevalence of sexual dysfunction in male subjects with alcohol dependence
Benegal, V., & Arackal, B. (2007) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.33257 · Cited by 108 · cited 1×
“Alcohol abuse is a well-known risk factor for the development of alcoholic cirrhosis (69), as well as a risk factor for ED in the general population (70).”
BackgroundViral hepatitis update: Progress and perspectives
Pisano, M. B., Giadans, C. G., Flichman, D. M., Ré, V. E., Preciado, M. V., & Valva, P. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i26.4018 · Cited by 102
Vignozzi, L., Filippi, S., Comeglio, P., Cellai, I., Sarchielli, E., Morelli, A., Rastrelli, G., Maneschi, E., Galli, A., Vannelli, G. B., et al. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.01.014 · Cited by 84
Association of Risk Factors and Medical Comorbidities with Male Sexual Dysfunctions
El-Sakka, A. I. (2007) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2006.00342.x · Cited by 83 · cited 1×
“Alcohol abuse is a well-known risk factor for the development of alcoholic cirrhosis (69), as well as a risk factor for ED in the general population (70).”
BackgroundAlterations of seminal and hormonal parameters: An extrahepatic manifestation of HCV infection
Durazzo, M. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i19.3073 · Cited by 79 · cited 1×
“Interferon, a commonly used medicine for the treatment of viral hepatitis, can cause patients to be depressed and prone to decreased libido and sexual dysfunction (75, 76).”
BackgroundKim, Y., Chang, Y., Cho, Y. K., Ahn, J., Shin, H., & Ryu, S. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.07.006 · Cited by 79 · cited 1×
“The main reason may be that NAFLD and ED share common risk factors such as obesity, hypertension, and diabetes mellitus (15, 16).”
BackgroundWang, Y. J., Wu, J.-C., Lee, S. D., Tsai, Y. T., & Lo, K.-J. (1991) · PubMed · Cited by 74
Psychosocial factors associated with male sexual difficulties
McCabe, M. P., & Connaughton, C. (2014) · The Journal of Sex Research · doi:10.1080/00224499.2013.789820 · Cited by 74
Male hypogonadism in cirrhosis and after liver transplantation
Foresta, C., Schipilliti, M., Ciarleglio, F. A., Lenzi, A., & D’Amico, D. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03346393 · Cited by 74 · cited 1×
“In addition, immunosuppressive therapy with steroid agents such as azathioprine, cyclosporine A, or tacrolimus can affect the hypothalamic-pituitary-gonadal axis by inhibiting androgen synthesis, leading to ED in liver transplant patients (78).”
BackgroundTada, T., Toyoda, H., Sone, Y., Yasuda, S., Miyake, N., Kumada, T., & Tanaka, J. (2019) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14734 · Cited by 73
Antihypertensive therapy causes erectile dysfunction
Chrysant, S. G. (2015) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000189 · Cited by 69 · cited 1×
“Moreover, some antihypertensive medications, such as beta-blockers, aldosterone receptor antagonists, and thiazide diuretics, can also induce ED (42).”
BackgroundDanoff, A., Khan, O., Wan, D. W., Hurst, L., Cohen, D. L., Tenner, C. T., & Bini, E. J. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00544.x · Cited by 68 · cited 1×
“hypothalamic-pituitary-gonadal axis (52).”
Wang, W., Fan, J., Huang, G., Zhu, X., Tian, Y., Tan, H., & Su, L. (2017) · Sexual Medicine · doi:10.1016/j.esxm.2016.10.001 · Cited by 68
Neong, S. F., Billington, E. O., & Congly, S. E. (2019) · Hepatology · doi:10.1002/hep.30359 · Cited by 67
Toda, K., Miwa, Y., Kuriyama, S., Fukushima, H., Shiraki, M., Murakami, N., Shimazaki, M., Ito, Y., Nakamura, T., Sugihara, J., et al. (2005) · Journal of Gastroenterology · doi:10.1007/s00535-005-1634-8 · Cited by 64
Chronic Advanced Liver Disease and Impotence: Cause and Effect?
Cornely, C. M., Schade, R. R., Thiel, D. H. V., & Gavaler, J. S. (1984) · Hepatology · doi:10.1002/hep.1840040622 · Cited by 62 · cited 2×
“Some scholars compared the incidence of ED among alcoholics with or without cirrhosis and diabetes, found that there was no difference between the groups (19).”
BackgroundErectile Dysfunction and Hepatitis C Virus Infection
Ferri, C., Bertozzi, M. A., & Zignego, A. L. (2002) · JAMA · doi:10.1001/jama.288.6.698 · Cited by 59 · cited 1×
“HCV patients with cryoglobulinemia have a higher incidence of ED than those without cryoglobulinemia (31).”
BackgroundHawksworth, D. J., & Burnett, A. L. “. (2019) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2019.01.002 · Cited by 58
Kraus, M. R., Schäfer, A., Bentink, T., Scheurlen, M., Weißbrich, B., Al‐Taie, O., & Seufert, J. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06007 · Cited by 56 · cited 1×
“Depression appeared to have a stronger correlation with sexual dysfunction than testosterone levels (47).”
BackgroundMansour, H. M., Salama, A., Abdelsalam, R. M., Ahmed, N. A., Yassen, N. N., & Zaki, H. F. (2018) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2018-0338 · Cited by 51 · cited 1×
“A decrease in liver stiffness measurement and fibrosis index based on 4 factor values were also observed in this study, possibly due to the antifibrotic effect of tadalafil (92).”
BackgroundBektaş, S., Karakaya, K., Can, M., Bahadır, B., Güven, B., Erdoğan, N., & Özdamar, Ş. O. (2016) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/j.kjms.2016.05.005 · Cited by 50 · cited 1×
“PDE5-I can protect the liver from ischemia-reperfusion injury through a variety of signaling pathways, such as increasing intracellular cGMP levels, activating protein kinase C and protein kinase G (93), leading to the activation of cGMP-dependent protein kinase, which in turn induces vasodilation, anti-inflammatory a…”
BackgroundDeficiency of eNOS exacerbates early-stage NAFLD pathogenesis by changing the fat distribution
Nozaki, Y., Fujita, K., Wada, K., Yoneda, M., Shinohara, Y., Imajo, K., Ogawa, Y., Kessoku, T., Nakamuta, M., Saito, S., et al. (2015) · BMC Gastroenterology · doi:10.1186/s12876-015-0409-9 · Cited by 49 · cited 14×
“This paper will cite a substantial amount of evidence to illustrate this issue, and these evidences, which are gathered from various literatures, varies Abbreviations: CLDs, chronic liver diseases; ED, erectile dysfunction; NAFLD, Non-alcoholic fatty liver disease. to some extent and is frequently not comparable, poss…”
BackgroundInfluentialTriglyceride‐Glucose Index (TyG) is associated with erectile dysfunction: A cross‐sectional study
Yılmaz, M., Karaaslan, M., Tonyalı, Ş., Celik, M., Toprak, T., & Odabaş, Ö. (2020) · Andrology · doi:10.1111/andr.12904 · Cited by 49
Erectile Dysfunction in End-Stage Liver Disease Men
Huyghe, E., Kamar, N., Wagner, F., Capietto, A.-H., El-Kahwaji, L., Muscari, F., Plante, P., & Rostaing, L. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.01169.x · Cited by 48 · cited 1×
“(58) used a questionnaire to survey patients with end-stage liver disease who were candidates for liver transplantation, using the IIEF-5 score to assess erectile function and the patient-baseline Treatment-Satisfaction Scale score to assess sexual satisfaction.”
MethodErectile dysfunction in patients with liver disease related to chronic hepatitis B
Kim, M. G., Kim, S. Y., Rou, W. S., Hwang, S. W., & Lee, B. S. (2015) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2015.21.4.352 · Cited by 47 · cited 2×
“Patients with HBV-related liver cirrhosis exhibited a higher prevalence and severity of ED than chronic hepatitis B patients (4, 28).”
BackgroundPaternostro, R., Heinisch, B. B., Reiberger, T., Mandorfer, M., Schwarzer, R., Seeland, B., Trauner, M., Peck‐Radosavljevic, M., & Ferlitsch, A. (2018) · Liver International · doi:10.1111/liv.13704 · Cited by 47 · cited 4×
“(18) discovered that among male cirrhotic patients, 55% were categorized as mild-to-moderate ED and 8.”
BackgroundInfluentialHypogonadotropic hypogonadism in men with hereditary hemochromatosis
Osta, R. E., Grandpré, N., Monnin, N., Hubert, J., & Koscinski, I. (2017) · Basic and Clinical Andrology · doi:10.1186/s12610-017-0057-8 · Cited by 45
Balhara, Y. P. S., Sarkar, S., & Gupta, R. (2015) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.159023 · Cited by 42
Tandon, P., Inayat, I., Tal, M., Spector, M., Shea, M. C., Groszmann, R. J., & García–Tsao, G. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.01.017 · Cited by 41
Fábregas, B. C., de Ávila, R. E., Faria, M. N., Moura, A. S., Carmo, R. A., & Teixeira, A. L. (2013) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2013.03.008 · Cited by 40
Dove, L. M., Rosen, R. C., Ramcharran, D., Wahed, A. S., Belle, S. H., Brown, R. S., & Hoofnagle, J. H. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.05.060 · Cited by 40 · cited 1×
“Interferon, a commonly used medicine for the treatment of viral hepatitis, can cause patients to be depressed and prone to decreased libido and sexual dysfunction (75, 76).”
BackgroundInsulin Resistance Is an Independent Determinate of ED in Young Adult Men
Chen, S., Wu, R., Huang, Y., Zheng, F., Yang-bin, O., Tu, X.-A., Zhang, Y., Gao, Y., Chen, X., Zheng, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083951 · Cited by 39 · cited 1×
“In addition to the aforementioned mechanisms, oxidative stress, inflammatory response, apoptosis, and other factors are also involved in the occurrence of CLDs-related ED (85, 86).”
BackgroundSelf-citationIs Erectile Dysfunction an Example of Abnormal Endothelial Function?
Blick, C., Ritchie, R. W., & Sullivan, M. (2016) · Current Vascular Pharmacology · doi:10.2174/1570161114666151202205950 · Cited by 39 · cited 1×
“HCV infection is more likely to cause inflammation of the vascular endothelium, which is one of the pathogenesis of ED (29, 30).”
BackgroundAssessment of sexual functions in patients with chronic liver disease
Şimşek, I., Aslan, G., Akarsu, M., Köseoğlu, H., & Esen, A. (2005) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901316 · Cited by 38 · cited 2×
“The total prevalence of ED in patients with chronic viral hepatitis ranges from 14 to 78% (20, 25), even after adjustment based on IIEF-5 scores ≤17, 40% of patients with chronic viral hepatitis had ED (26).”
BackgroundSexual dysfunction in men with alcoholic liver cirrhosis. A comparative study
Jensen, S. B., Gluud, C. N., & The Copenhagen Study Group for Liver Diseases (1985) · Liver International · doi:10.1111/j.1600-0676.1985.tb00221.x · Cited by 37 · cited 1×
“conclusion that alcohol was the true cause of ED (32).”
BackgroundHypertension might be a risk factor for erectile dysfunction: a meta-analysis
Ning, L., & Yang, L. (2017) · Andrologia · doi:10.1111/and.12644 · Cited by 37
Pre-analytical issues for testosterone and estradiol assays
Raff, H., & Sluss, P. M. (2008) · Steroids · doi:10.1016/j.steroids.2008.05.005 · Cited by 36 · cited 1×
“However, what calls for special attention is that physiological decline should also be fully taken into account when analyzing testosterone levels in patients with CLDs, testosterone in men decays at a rate of 10% every decade after the age of 30 (67).”
BackgroundHohenstein, B., Daniel, C., Wittmann, S., & Hugo, C. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn319 · Cited by 34 · cited 2×
“(96, 97) and significantly better than vardenafil, another metaanalysis failed to show this significance (98).”
BackgroundSildenafil does not influence hepatic venous pressure gradient in patients with cirrhosis
Clemmesen, J. O., Giraldi, A. G. E., Ott, P., Dalhoff, K., Hansen, B. A., & Larsen, F. S. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.6208 · Cited by 32 · cited 1×
“These studies had also shown that PDE-5 inhibitors could be safely used in Child’s A and B cirrhosis, and they might be considered as a treatment option for CLDs patients (89, 90), but these studies had not documented the efficacy in patients with cirrhosis.”
BackgroundQuality of Life, Depression, and Anxiety Among Hepatitis B Patients
Keskin, G., Gümüş, A. B., & Orgun, F. (2013) · Gastroenterology Nursing · doi:10.1097/sga.0b013e3182a788cc · Cited by 32
Alcoholic hypogonadism: Hormonal response to clomiphene
Martínez-Riera, A., Santolaria-Fernández, F. J., Reimers, E. G., Milena, A., Gómez-Sirvent, J. L., Rodríguez-Moreno, F., González-Martín, I., & Rodríguez-Rodríguez, E. (1995) · Alcohol · doi:10.1016/0741-8329(95)02006-3 · Cited by 30
Erectile Dysfunction in Liver Transplant Patients
Huyghe, É., Kamar, N., Wagner, F., Yeung, S. J., Capietto, A.-H., El-Kahwaji, L., Muscari, F., Plante, P., & Rostaing, L. P. E. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02424.x · Cited by 29 · cited 1×
“Significant differences were found in total testosterone, sex hormone-binding globulin, free androgen index, and the International Index of Erectile Function-5 (IIEF-5) scores pre- and post-operation (6, 7), which confirmed an association between CLDs and ED.”
BackgroundReriani, M., Flammer, A. J., Li, J., Prasad, M., Rihal, C. S., Prasad, A., Lennon, R. J., Lerman, L. O., & Lerman, A. (2014) · Coronary Artery Disease · doi:10.1097/mca.0000000000000145 · Cited by 29 · cited 1×
“Chronic systemic inflammation with elevated C-reactive protein levels reduces the synthesis of NO in endothelial cells and ultimately leads to endothelial dysfunction, which may account for the relationship between ED and chronic hepatitis (49, 50).”
BackgroundErectile dysfunction in compensated liver cirrhosis
Maimone, S., Saffioti, F., Oliva, G., Benedetto, A. D., Alibrandi, A., Filomia, R., Caccamo, G., Saitta, C., Cacciola, I., Pitrone, C., et al. (2018) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.10.015 · Cited by 28 · cited 3×
“(34) observed no significant relationship between the prevalence or severity of ED and alcohol consumption.”
BackgroundInfluentialGentile, I., Fusco, F., Buonomo, A. R., Scotto, R., Zappulo, E., Pinchera, B., Persico, F., Califano, G., Borgia, G., & Longo, N. (2018) · Sexual Health · doi:10.1071/sh17168 · Cited by 26
Huang, S., Lin, C., Chan, C.-H., Loh, E., & Lan, T. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.06.012 · Cited by 25
Male sexual disturbances in liver diseases: What do we know?
Durazzo, M., Premoli, A., Bisceglie, C. D., Bo, S., Ghigo, E., & Manieri, C. (2010) · Journal of Endocrinological Investigation · doi:10.1007/bf03346632 · Cited by 25 · cited 3×
“Oral testosterone seemed to have no positive effect on sexual dysfunction in patients with cirrhosis, and androgen supplementation was only effective in cases of severe hypogonadism with testicular atrophy (51), implying that the main mechanism for ED may not be limited to total testosterone levels.”
BackgroundInfluentialChung, S., Keller, J. J., Liang, Y., & Lin, H. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02663.x · Cited by 24
Yoo, H. J., Lee, B., Jung, E., Kim, S. G., Kim, Y. S., & Yoo, J. (2021) · Hepatology International · doi:10.1007/s12072-021-10270-y · Cited by 24
Pircher, J., Czermak, T., Merkle, M., Mannell, H., Krötz, F., Ribeiro, A., Vielhauer, V., Nadjiri, J., Gaitzsch, E., Niemeyer, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113351 · Cited by 23
Association of erectile dysfunction with depression in patients with chronic viral hepatitis
Ma, B. O. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i18.5641 · Cited by 21 · cited 4×
“The total prevalence of ED in patients with chronic viral hepatitis ranges from 14 to 78% (20, 25), even after adjustment based on IIEF-5 scores ≤17, 40% of patients with chronic viral hepatitis had ED (26).”
BackgroundInfluentialElKhoury, F. F., Rambhatla, A., Mills, J. N., & Rajfer, J. (2017) · Urology · doi:10.1016/j.urology.2017.07.030 · Cited by 20
Benaragama, K. S., Singh, A. A., Taj, T., Hague, J., Boyle, J. R., & Richards, T. (2020) · Vascular and Endovascular Surgery · doi:10.1177/1538574420952923 · Cited by 20
Nishitani, S., & Takehana, K. (2004) · Hepatology Research · doi:10.1016/j.hepres.2004.08.006 · Cited by 18
Adverse effects of high-dose interferon-α-2a treatment for chronic hepatitis B
Kartal, E. D., ALPAT, S. N., Özgüneş, İ., & Usluer, G. (2007) · Advances in Therapy · doi:10.1007/bf02877700 · Cited by 18
Gonçalves, F. Z., Neto, F. S. L., Novais, P. C., Gattás, D., Lourenço, L., de Carvalho, C. A. M., Tirapelli, D. P. D. C., Molina, C. A. F., Tirapelli, L. F., & Tucci, S. (2018) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20176329 · Cited by 17 · cited 1×
“First, it can negatively affect endothelial function, resulting in an imbalance between NO and endothelin-1, which causes relaxation disorder of smooth muscle cells (35); second, it can increase the levels of advanced glycosylation end products, which can interfere with the synthesis of protein polymerase chains and m…”
BackgroundTomada, N., Tomada, I., Botelho, F. B., Pacheco‐Figueiredo, L., Lopes, T., Negrão, R., Pestana, M., & Cruz, F. (2013) · Andrology · doi:10.1111/j.2047-2927.2013.00102.x · Cited by 15 · cited 1×
“In addition to the aforementioned mechanisms, oxidative stress, inflammatory response, apoptosis, and other factors are also involved in the occurrence of CLDs-related ED (85, 86).”
BackgroundChiang, H.-C., Chien, Y.-C., Lin, P., Lee, H.-L., & Chen, Y. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206438 · Cited by 13
Thakur, J., Rathi, S., Grover, S., Chopra, M., Agrawal, S., Taneja, S., Duseja, A. K., Bhansali, A. K., Chawla, Y. K., & Dhiman, R. K. (2018) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2018.07.007 · Cited by 12 · cited 2×
“(87) conducted a prospective study in which 25 cirrhotic patients with Child-Pugh scores between 5 and 10 were enrolled.”
BackgroundNeurocognitive impairment is associated with erectile dysfunction in cirrhotic patients
Philonenko, S., Rivière, P., Mallet, M., Poullenot, F., Tripon, S., Munteanu, M., Boukherrouf, R., Sultanik, P., Rouprêt, M., Thabut, D., et al. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2019.03.030 · Cited by 9 · cited 1×
“identified minimal hepatic encephalopathy as a possible risk factor for the progression of ED (55).”
BackgroundPredicting risk of erectile dysfunction in patients with nonalcoholic fatty liver disease
Yılmaz, M., Odabaş, Ö., Karaaslan, M., Guler, O. F., Toprak, T., Biçer, S., & Tonyalı, Ş. (2021) · Andrologia · doi:10.1111/and.14091 · Cited by 8
Causes of erectile dysfunction in non-alcoholic fatty liver disease
Kani, H. T. (2021) · Hepatology forum/Hepatology forum (Online) · doi:10.14744/hf.2021.2021.0012 · Cited by 7 · cited 2×
“Therefore, careful evaluation of psychological status during diagnosis and treatment is important (14).”
BackgroundSağ, S., Yeşilbursa, D., & Güllülü, S. (2014) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2014.7688 · Cited by 6 · cited 1×
“Sildenafil has been used for the treatment of portopulmonary hypertension in liver transplant patients in order to ensure the success of transplantation (88).”
MethodKumar, A., Saraswat, V. A., Pande, G., & Kumar, R. (2022) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2022.01.009 · Cited by 6 · cited 2×
“It was discovered that erectile function improved significantly in all patients after 12 weeks of treatment, with only 25% of patients still having ED at 6 months of follow-up (91).”
BackgroundErectile dysfunction in patients with liver cirrhosis
Riggio, O., Ridola, L., Gioia, S., & Nardelli, S. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2019.05.011 · Cited by 3 · cited 1×
“This could be due to the sample size restrictions, which make it challenging to distinguish the effects of the two variables, liver dysfunction and cognitive impairment (57).”
Background
Cited by
The chronic alcohol consumption influences the gonadal axis in men: Results from a meta‐analysis
Santi, D., Cignarelli, A., Baldi, M., Sansone, A., Spaggiari, G., Simoni, M., & Corona, G. (2024) · Andrology · doi:10.1111/andr.13526 · Cited by 17
“96 In particular, the liver produces proteins essential for the transport and the homeostasis of steroid hormones, such as SHBG.”
BackgroundMechanisms of erectile dysfunction induced by aging: A comprehensive review
Zhuang, B., Zhuang, C., Jiang, Y., Zhang, J., Zhang, Y., Zhang, P., Yu, X., & Xu, S. (2024) · Andrology · doi:10.1111/andr.13778 · Cited by 23
Profound Sexual Dysfunction Among Patients with Hidradenitis Suppurativa: A Cross-sectional Study
Krajewski, P. K., Strobel, A., Schultheis, M., Staubach, P., Grabbe, S., Hennig, K., Matusiak, Ł., von Stebut, E., Garcovich, S., Bayer, H., et al. (2024) · Dermatology and Therapy · doi:10.1007/s13555-024-01196-y · Cited by 10
“Inter-estingly, the prevalence of ED in patients with HS is similar to that of patients with chronic liver disease [52], chronic kidney disease (stages 3–5) [53], celiac disease [54], and diabetes [55].”
BackgroundResultYou-cheng, L., Wu, X., & Zhufeng, C. (2024) · International Journal of Impotence Research · doi:10.1038/s41443-024-00914-6 · Cited by 8
Autophagy in erectile dysfunction: focusing on apoptosis and fibrosis
Luo, P., Zou, J., Chen, T., Zou, J., Li, W., Chen, Q., Cheng, L., Zheng, L., & Qian, B. (2024) · Asian Journal of Andrology · doi:10.4103/aja202433 · Cited by 11
Metadata
- Authors
- Zang, G., Sun, X., Sun, Y., Zhao, Y., Dong, Y., Pang, K., Cheng, P., Wang, M., & Zheng, Y.
- Affiliations
- Xuzhou Central Hospital (CN)
- Bengbu Medical College (CN)
- Corresponding author
- Zhao, Yan
- Venue
- Frontiers in Public Health
- Publisher
- Frontiers Media SA
- Published
- 2023-01-06
- Volume
- 10
- Pages
- 1092353-1092353
- ISSN
- 2296-2565 (ISSN-L)
- PMC
- PMC9853559
- OpenAlex
- W4313625137
- Cited by
- 21
- References
- 98
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 9 · 2023: 1
- FWCI
- 0.96
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Public Health (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Government of Jiangsu Province
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- chronic liver disease, erectile dysfunction, liver cirrhosis, sex steroid metabolism, lipid metabolism, glucose metabolism, liver transplantation, risk factors, prevalence, male patients
- MeSH terms
- Humans, Erectile Dysfunction, Lipids, Liver Cirrhosis, Male, Risk Factors, Gonadal Steroid Hormones
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
